Evidence map›Paper›PMID 32483418›Full record

ArticleTheranostics2020

Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents.

Jyoti Roy, Suraj U Hettiarachchi, Miranda Kaake, Ramesh Mukkamala, Philip S Low

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Preclinical Fluorescence-Guided Imaging Leveraging Surrounding Sentinel Tumor Microenvironment Identifies High-Risk Premalignant Pancreatic Lesions.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. EJNMMI radiopharmacy and chemistry · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jyoti RoyDepartment of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, Indiana 47907, United States.
Suraj U HettiarachchiDepartment of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, Indiana 47907, United States.
Miranda KaakeDepartment of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, Indiana 47907, United States.
Ramesh MukkamalaDepartment of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, Indiana 47907, United States.
Philip S LowDepartment of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, Indiana 47907, United States.
Purdue University West Lafayette · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic AgentsCancer-Associated FibroblastsCell Line, TumorEndopeptidasesFemaleFibroblast Activation Protein AlphaFibroblastsFluorescent DyesHumansMembrane ProteinsMiceMice, NudeMice, SCIDOptical ImagingTomography, Emission-Computed, Single-PhotonAntineoplastic AgentsEndopeptidasesFibroblast Activation Protein AlphaFluorescent DyesMembrane Proteinscancer-associated fibroblastchemotherapyFibroblast activation protein alphaoptical imagingSPECT imagingtubulysin therapytumor microenvironment

Identifiers

PMID32483418
PMCPMC7254991
OpenAlexW3021215586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.